Dynamic Metabolic Flux Framework for Enzymatic Efficiency Optimization in Biochemical Pathways

Thesis Abstract

The efficient orchestration of metabolic fluxes remains a fundamental barrier to optimizing enzymatic performance within biochemical pathways, where nonlinear kinetics, regulatory feedback, and resource allocation constrain throughput and yield under varying cellular conditions. This study develops a Dynamic Metabolic Flux Framework (DMFF) to optimize enzymatic efficiency by integrating kinetic modeling, control theory, and data-driven inference to predict trajectory-appropriate flux distributions that maximize conversion rates while minimizing energy and resource expenditure. The aims are to (1) formulate a dynamical, multiscale model that couples enzyme turnover with pathway-level fluxes under temporal perturbations; (2) identify robust control strategies grounded in nonlinear control and model-predictive control (MPC) to stabilize high-efficiency states; and (3) validate the framework against synthetic and semi-natural pathways to demonstrate generalizability across biochemical systems. The methodological design employs a mixed-methods approach anchored in systems biology and process engineering. The population comprises in silico pathway models featuring 6–12 enzymatic steps with allosteric regulation, complemented by in vitro kinetic datasets from three representative enzyme ensembles glycolytic,?amino acid biosynthesis, and fatty acid elongation modules. A sample of 20 pathway configurations, including perturbation scenarios (substrate variability, allosteric effector shifts, and cofactor availability), is generated programmatically. Data collection uses a combination of published kinetic parameters sourced from BRENDA and SABIO-RK, supplemented by bespoke enzyme turnover simulations. Instrumentation includes high-resolution ordinary differential equation (ODE) solvers, parameter identifiability routines, and stochastic perturbation modules to emulate intracellular noise. Validity and reliability are ensured through parameter cross-validation against experimental turnover data and sensitivity analyses (Morris screening and variance-based Sobol indices). Analytical methods comprise (i) nonlinear dynamic optimization via model-predictive control to derive time-varying flux targets, (ii) Bayesian parameter inference to quantify uncertainty in kinetic constants, (iii) regression analysis to link pathway topologies and regulatory motifs with achieved catalytic efficiency, (iv) ANOVA to assess the significance of perturbation effects on flux stability, and (v) comparative performance evaluation against static flux baselines using metrics such as Catalytic Efficiency Gain (CEG), Pathway Throughput (PTH), and Energetic Cost per Product (ECPP). A hierarchical model specification situates enzyme-level kinetics within pathway-level dynamical equations, enabling the DMFF to adapt flux distributions in response to temporal disturbances. The theoretical underpinnings draw on nonlinear control theory, metabolic control analysis, and information-theoretic perspective on regulatory signals, with explicit incorporation of two named theories Metabolic Control Analysis (MCA) and Model Predictive Control (MPC). Expected findings indicate that DMFF-produced trajectories achieve sustained higher specific productivity with reduced ATP and NAD(P)H overhead compared to static flux configurations, especially under substrate fluctuations and regulatory perturbations. It is anticipated that robust control strategies will identify critical control points (e.g., rate-limiting steps and allosteric nodes) whose modulation yields disproportionate improvements in enzymatic efficiency. The study also expects to reveal a universal design principle balanced flux allocation coupled with anticipatory regulation outperforms reactive adjustments in maintaining high-efficiency states across diverse pathway architectures. The contribution to knowledge includes (i) a formally defined, transferable DMFF that integrates kinetic, regulatory, and control-theoretic perspectives to optimize enzymatic efficiency; (ii) a generalized framework capable of guiding experimental pathway engineering and bioprocess optimization with explicit performance metrics; and (iii) methodological innovations in combining MPC with MCA-informed sensitivity analyses to identify robust, scalable targets for metabolic optimization. The conclusions will advocate adopting dynamic, model-predictive strategies as standard practice for enzymatic pathway optimization, and recommendations will emphasize leveraging real-time data assimilation, interdisciplinary collaboration between biochemists and control engineers, and the development of accessible software tools to disseminate the framework for broader application in industrial biotechnology and metabolic engineering.